Close menu




December 22nd, 2020 | 09:49 CET

Daimler, dynaCERT, Tesla, Volkswagen - state-subsidized share gains

  • Investments
Photo credits: pixabay.com

The German energy transition and the change in mobility can be summarized in one sentence: maximum effort for minimum success. While the impact of the German population on global environmental responsibilities is marginal, the financial burden is enormous. The introduction of battery cars has already failed and is now only getting off the ground thanks to unprecedentedly high premiums on a new purchase. The original selling point that battery cars are better for the environment has failed miserably. The federal government is now engaging in damage control and appealing to subsidy hunters. On top of that, the acquisition is now sweetened with a state-subsidized charging station. Speculators are rubbing their hands.

time to read: 2 minutes | Author: Mario Hose
ISIN: CA26780A1084 , DE0007100000 , US88160R1014 , DE0007664039

Table of contents:


    Competitive disadvantages due to politics

    When politics interferes in the economy, it threatens to incur costs that often have to be borne by taxpayers. In Germany, citizens and companies are already paying the highest electricity prices, and there is no end in sight. The reason lies primarily in the levies and fees for building a grid with renewable energies. Only 45% of the electricity in Germany comes from renewable sources.

    Electricity does not originate in the socket

    The shutdown of Germany's safe nuclear power plants means that consumers are becoming more dependent on neighbouring countries. As long as coal-fired power plants are still allowed to be on the grid in Germany, they will fill the supply gap caused by the loss of nuclear energy. Energy suppliers have received hefty compensation from the Merkel government for shutting down nuclear power plants.

    A drop in the bucket

    Subsidies for battery cars are putting Daimler and Volkswagen and their suppliers under increasing pressure. While Berlin-Brandenburg's political celebrities celebrate the construction of a Tesla plant, families in Bavaria and Baden-Württemberg are left out in the cold, as the government-initiated transformation causes job losses and uncertainty there. More and more new names of battery car manufacturers are appearing on the stock lists, benefiting from subsidies from various nations and giving shareholders a share price firework display.

    Environmental protection comes first

    The earth is our planet, and it must be cared for - environmental protection is, therefore, a top priority. Against this background, it is abstruse that politicians are using taxpayers' money to promote a technology that will create more electricity demand and significantly change the procurement of raw materials. The overexploitation of Mother Earth becomes a burden for the people affected. Also, battery disposal is a problem that will assume significant proportions in the coming years. How will the quantities of pollutants from the batteries be disposed of and who will pay for it?

    An environmentally friendly alternative

    A viable solution that makes an uncomplicated contribution to environmental protection comes from dynaCERT. The Canadian CleanTech Company has brought to market a hydrogen technology for retrofitting diesel engines that significantly increases efficiency and reduces emissions of pollutants. The Company is working with the United Nations, and well-known investors, like Eric Sprott, are already invested. Until there are viable alternatives to diesel engines in many areas of transportation, the dynaCERT technology will be more than just a bridging technology. CO2-based tolling may be another market opportunity for the product.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read